Ligand Pharmaceuticals Inc Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 83.66%88.53%88.30%85.84%91.93%94.89%96.20%97.48%90.57%81.40%74.26%73.08%91.99%93.37%
EBT Margin -25.35%-65.44%-11.85%-12.31%18.80%17.51%49.13%7.30%40.56%68.93%662.31%0.79%29.89%18.35%48.48%1.51%
EBIT Margin -25.60%-124.50%-2.92%0.61%30.51%30.41%38.00%40.27%48.25%65.11%670.99%22.93%42.99%1.55%9.09%-13.53%
EBITDA Margin -25.60%-124.50%-2.92%0.61%30.51%30.41%38.00%40.27%48.25%65.11%670.99%22.93%42.99%1.55%9.09%-13.53%
Operating Margin -25.60%-124.50%-2.92%0.61%30.51%30.41%38.00%40.27%48.25%65.11%670.99%22.93%42.99%1.55%9.09%-13.53%
Net Margin 16.41%10.25%0.01%11.65%5.28%19.84%316.27%0.67%8.90%57.00%523.19%-5.86%-7.96%-14.34%-1.27%-2.41%
FCF Margin -88.14%-116.31%-4.16%1.48%42.79%31.86%57.89%54.03%61.24%76.82%-26.51%30.65%29.00%61.11%35.07%56.98%
Efficiency
Inventory Average 1.50M1.54M0.83M0.95M1.78M3.15M5.75M7.21M16.89M26.91M20.31M18.63M19.04M
Assets Average 98.07M112.42M104.49M181.37M380.55M552.32M636.30M965.91M1,377.86M1,428.60M1,329.94M1,030.13M774.94M864.50M
Equity Average -0.55M1.67M17.34M38.05M37.97M131.80M289.29M370.54M480.35M664.07M738.38M765.34M709.32M649.20M765.68M
Invested Capital 3.74M-4.85M18.18M26.48M49.61M271.32M482.28M554.20M624.32M587.35M767.23M716.23M821.26M597.53M700.94M830.51M
Asset Utilization Ratio 0.310.280.470.360.190.200.220.260.090.110.180.190.170.19
Leverage & Solvency
Interest Coverage Ratio -36.91-505.24-0.353.425.063.3922.581.375.291.6918.20-7.44
Debt to Equity 3.700.517.441.720.620.560.050.13
Debt Ratio 0.250.130.760.810.350.330.020.10
Equity Ratio -0.060.070.250.470.100.470.570.600.440.510.520.630.780.890.88
Times Interest Earned -36.91-505.24-0.353.425.063.3922.581.375.291.6918.20-7.44
Valuation
Enterprise Value 229.21M160.57M224.83M401.68M1,057.60M896.19M1,960.13M1,982.62M2,699.63M2,165.75M761.82M1,189.10M2,240.17M916.62M1,074.97M1,768.47M
Market Capitalization 245.25M174.92M233.53M414.06M1,073.58M1,065.43M2,160.35M2,123.67M2,889.97M2,884.13M1,831.69M1,600.28M2,581.28M1,128.49M1,245.28M2,024.64M
Return Ratios
Return on Sales 0.16%0.10%0.00%0.12%0.05%0.17%3.16%0.01%0.09%0.57%5.23%-0.06%-0.08%-0.14%-0.01%-0.02%
Return on Capital Employed -0.02%0.00%0.20%0.12%0.17%0.13%0.17%0.19%0.59%0.03%0.08%0.00%0.02%-0.03%
Return on Invested Capital 43.99%0.01%0.38%0.12%0.03%0.22%0.94%0.02%
Return on Assets 0.00%0.03%0.02%0.06%0.60%0.00%0.02%0.15%0.46%-0.01%-0.01%-0.03%0.00%0.00%
Return on Equity -4.36%0.00%0.21%0.07%0.29%1.73%0.00%0.03%0.30%0.95%-0.01%-0.03%-0.04%0.00%-0.01%